Global overview of injecting drug use and HIV infection among injecting drug users, AIDS, vol.18, issue.17, pp.2295-2303, 2004. ,
DOI : 10.1097/00002030-200411190-00010
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis, Lancet, vol.368, pp.451-458, 2006. ,
Evidence for Action: A critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users, International Journal of Drug Policy, vol.16, pp.1-6, 2005. ,
DOI : 10.1016/j.drugpo.2005.08.003
Survival in patients with HIV infection and viral hepatitis Bor C: a cohort study, AIDS, vol.18, pp.2081-2085, 2004. ,
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy, Antiviral Therapy, vol.10, pp.53-61, 2000. ,
Pharmacokinetic Drug Interactions Between Opioid Agonist Therapy and Antiretroviral Medications, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.5, pp.563-572, 2006. ,
DOI : 10.1097/01.qai.0000219769.89679.ec
Mortality in heroin-assisted treatment in Switzerland 1994???2000, Drug and Alcohol Dependence, vol.79, issue.2, pp.137-143, 1994. ,
DOI : 10.1016/j.drugalcdep.2005.01.005
Drug injecting, rapid HIV spread and the " risk environment, AIDS, vol.13, pp.259-269, 1999. ,
Explosive spread and high prevalence of HIV infection among injecting drug users in, pp.25-31, 2002. ,
Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain, AIDS Research and Human Retroviruses, vol.228, pp.715-723, 2006. ,
Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers, AIDS, vol.20, issue.1, pp.67-71, 2005. ,
DOI : 10.1097/01.aids.0000196178.73174.24
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol, Journal of Hepatology, vol.42, issue.6, pp.799-805 ,
DOI : 10.1016/j.jhep.2005.01.022
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. The Lancet, pp.378-384, 2005. ,
Hepatitis C and Progression of HIV Disease, JAMA, vol.288, issue.2, pp.241-244, 2002. ,
DOI : 10.1001/jama.288.2.199
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy, AIDS, vol.20, issue.8, pp.1171-1180, 2006. ,
DOI : 10.1097/01.aids.0000226958.87471.48
Long-term Outcome of Chronic Drug Use: The Amsterdam Cohort Study among Drug Users, American Journal of Epidemiology, vol.161, issue.3, pp.271-279, 2005. ,
DOI : 10.1093/aje/kwi035
Effect of Hard-Drug Use on CD4 Cell Percentage, HIV RNA Level, and Progression to AIDS-Defining Class C Events Among HIV-Infected Women, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.37, issue.3, pp.1423-1430, 2004. ,
DOI : 10.1097/01.qai.0000127354.78706.5d
Combating AIDS in the developing world. Task force on HIV/AIDS, Malaria, TB and access to essential Medicines, 2005. ,
Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?, European Journal of Epidemiology, vol.13, issue.9, pp.795-804, 2005. ,
DOI : 10.1007/s10654-005-1049-0
Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001. ,
Effectiveness of sterile needle and syringe programmes, International Journal of Drug Policy, vol.16, pp.31-44, 2005. ,
DOI : 10.1016/j.drugpo.2005.02.004
Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users, AIDS, vol.19, issue.8, pp.837-839, 2005. ,
DOI : 10.1097/01.aids.0000168982.20456.eb